All Wegovy dose strengths are back on US market
After a year plagued by supply issues, Novo Nordisk can now supply the US market with all dose strengths of the much sought-after obesity treatment.
by ulrich quistgaard, translated by daniel pedersen
All dose strengths of Novo Nordisk’s obesity drug, Wegovy, are now available in the US, reports Danish business media Børsen citing a company statement provided to TV broadcast 60 Minutes.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
